SEARCH

SEARCH BY CITATION

References

  • 1
    Shimon, I., Ram, Z., Cohen, Z.R. et al. (2002) Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery, 51, 5761.
  • 2
    Hammer, G.D., Tyrrell, J.B., Lamborn, K.R. et al. (2004) Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism, 89, 63486357.
  • 3
    Atkinson, A.B., Kennedy, A., Wiggam, M.I. et al. (2005) Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clinical Endocrinology, 63, 549559.
  • 4
    Tritos, N.A. & Biller, B.M.K. (2012) Advances in medical therapies for Cushing's syndrome. Discovery Medicine, 13, 171179.
  • 5
    Fleseriu, M. & Petersen, M. (2012) Medical management of Cushing's disease: what is in the future? Pituitary, 15, 330341.
  • 6
    Castinetti, F., Morange, I., Jaquet, P. et al. (2008) Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease. European Journal of Endocrinology, 158, 9199.
  • 7
    Colao, A., Petersenn, S., Newell-Price, J. et al. (2012) A 12-month phase 3 study of pasireotide in Cushing's disease. The New England Journal of Medicine, 366, 914924.
  • 8
    Fleseriu, M., Biller, B.M., Findling, J.W. et al. (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 97, 20392049.
  • 9
    Landis, R.J. & Koch, G.G. (1977) The measurement of observer agreement for categorical data. Biometrics, 33, 159174.
  • 10
    Fleiss, J.L. & Cohen, J. (1973) The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educational Psychological Measurement, 33, 613619.
  • 11
    van der Pas, R., de Herder, W.W., Hofland, L.J. et al. (2012) New developments in the medical treatment of Cushing's syndrome. Endocrine-Related Cancer, 19, R205R223.
  • 12
    Feelders, R.A. & Hofland, L.J. (2013) Medical treatment of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 98, 425438.
  • 13
    Giraldi, F.P., Moro, M. & Cavagnini, F. (2003) Gender-related differences in the presentation and course of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 88, 15541558.
  • 14
    Franconi, F., Brunelleschi, S., Steardo, L. et al. (2007) Gender differences in drug responses. Pharmaceutical Research, 55, 8195.
  • 15
    Wallia, A., Colleran, K., Purnell, J.Q. et al. (2013) Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects. Diabetes Care, 36, e147e148.
  • 16
    Auchus, R., McPhaul, M.J., Findling, J.W. et al. (2012) Predicting and managing hypertension and hypokalemia in Cushing syndrome during mifepristone therapy. Endocrine Reviews, 33 (03 Meeting abstracts), MON–450.
  • 17
    Slora, E.J., Bocian, A.B., Herman-Giddens, H. et al. (2009). Assessing inter-rater reliability (IRR) of Tanner staging and orchidometer use with boys: a study from PROS. Journal of Pediatric Endocrinology & Metabolism, 22, 291299.
  • 18
    Lucky, A.W., Barber, B.L., Girman, C.J. et al. (1996) A multirater validation study to assess the reliability of acne lesion counting. Journal of the American Academy of Dermatology, 35, 559565.
  • 19
    Sonino, N., Boscaro, M., Fallo, F. et al. (2000) A clinical index for rating severity in Cushing's syndrome. Psycotherapy and Psychosomatics, 69, 216220.
  • 20
    Kellner, R. (1972) Improvement criteria in drug trials with neurotic patients. Psychological Medicine, 2, 7380.
  • 21
    Lindsay, J.R., Nansel, T., Baid, S. et al. (2006) Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. Journal of Clinical Endocrinology and Metabolism, 91, 447453.
  • 22
    van Aken, M.O., Pereira, A.M., Biermasz, N.R. et al. (2005) Quality of life in patients after long-term biochemical cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 90, 32793286.
  • 23
    Doshi, A., Zaheer, A. & Stiller, M.J. (1997) A comparison of current acne grading systems and proposal of a novel system. International Journal of Dermatology, 36, 416418.
  • 24
    Hatch, R., Rosenfield, R.L., Kim, M.H. et al. (1981) Hirsutism: implications, etiology and management. American Journal of Obstetrics and Gynecology, 140, 815830.
  • 25
    Butler, A.A., Menant, J.C., Tiedemann, A.C. et al. (2009) Age and gender differences in seven tests of functional mobility. Journal of Neuroengineering and Rehabilitation, 6, 31.
  • 26
    Lord, S.R., Murray, S.M., Chapman, K. et al. (2002) Speed, balance and psychological status in older people. Journal of Gerontology, 57A, M539M543.
  • 27
    Mathiowetz, V., Kashman, N., Volland, G. et al. (1985) Grip and pinch strength: normative data for adults. Archives of Physical Medicine and Rehabilitation, 66, 6974.
  • 28
    Beck, A.T., Steer, R.A. & Brown, G. (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio, TX.
  • 29
    Reitan, R.M. & Wolfson, D. (1985) Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Neuropsychological Press, Tuscon, AZ.
  • 30
    Tombaugh, T.N. (2004) Trail Making Test A and B: normative data stratified by age and education. Archives of Clinical Neuropsychology, 19, 203214.
  • 31
    Ware, J.E. Jr, Kosinski, M., Bjorner, J.B. et al. (2007) User's manual for the SF-36v2™ Health Survey, 2nd edn. Quality Metric Incorporated, Lincoln, RI.